Spirepoint Private Client’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.26M Buy
75,425
+1,861
+3% +$78.9K 0.26% 64
2026
Q1
$2.87M Buy
73,564
+3,562
+5% +$144K 0.27% 68
2025
Q4
$2.86M Buy
70,002
+4,248
+6% +$173K 0.27% 69
2025
Q3
$2.65M Buy
65,754
+1,082
+2% +$41.7K 0.28% 74
2025
Q2
$2.38M Sell
64,672
-6,305
-9% -$214K 0.27% 74
2025
Q1
$2.36M Buy
+70,977
New +$2.47M 0.31% 65

Other funds holding RECS

Spirepoint Private Client's RECS Position: Q2 2026 in Review

Spirepoint Private Client increased its Columbia Research Enhanced Core ETF (RECS) stake by 2.5% in Q2 2026, buying an estimated $78.9K and bringing the position to 75,425 shares worth $3.26M. The position accounts for 0.26% of the portfolio, ranked #64.

Spirepoint Private Client first reported a position in RECS in Q1 2025 and has held it in 6 quarters since. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • Spirepoint Private Client held 75,425 shares of Columbia Research Enhanced Core ETF worth $3.26M as of Q2 2026.
  • Spirepoint Private Client bought 1,861 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $78.9K.
  • Columbia Research Enhanced Core ETF made up 0.26% of Spirepoint Private Client's portfolio in Q2 2026, its #64 holding.
  • Spirepoint Private Client first reported a position in Columbia Research Enhanced Core ETF in Q1 2025 and has held it in 6 quarters since.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on Spirepoint Private Client's 13F filing for Q2 2026, filed 5 Aug 2026.